To begin with, I would like to say that there are certain activities that are ongoing, and international comparisons by the Organization for Economic Co-operation and Development in Paris show that Canada's performance is very good compared with that of other countries that regulate the same areas.
In carrying out our responsibilities from day to day we take an almost continuous risk-assessment approach. For example, it came to our attention in 2004 that there were risks involving Vioxx and other similar drugs. We took immediate action to invest resources in order to deal with the problems, to try to regulate that area, which included asking cabinet, and eventually Parliament for new resources.
We make adjustments every day.
I would also say, in response to the criticism in the Auditor General's report, that we can improve our planning system. As I said in my opening remarks, Health Canada is doing a great deal to improve its planning in order to be able to determine the exact level of activity that it needs to undertake.